DeCell Technologies seeded with $250k to improve healing of wounds
Halifax, Nova Scotia-based DeCell Technologies Inc, a biomedical device manufacturer, has received $250,000 in seed-stage funding from Canadian early-stage venture capital firm Innovacorp. Investment proceeds will be used to finance development of the company's first product for the treatment of diabetic foot ulcers. Founded in 2012, DeCell is based in Innovacorp Enterprise Centre, an incubation facility for life sciences and clean technology start-ups located at Dalhousie University.
13 November 2013•2 mins read
